Runcaciguat

CAS No. 1402936-61-1

Runcaciguat ( —— )

Catalog No. M26816 CAS No. 1402936-61-1

Runcaciguat is a soluble guanylate cyclase stimulator. Runcaciguat combines with selective partial adenosine A1 receptor agonists and can be used in studies about cardiovascular and renal diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 222 Get Quote
10MG 402 Get Quote
25MG 665 Get Quote
50MG 888 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Runcaciguat
  • Note
    Research use only, not for human use.
  • Brief Description
    Runcaciguat is a soluble guanylate cyclase stimulator. Runcaciguat combines with selective partial adenosine A1 receptor agonists and can be used in studies about cardiovascular and renal diseases.
  • Description
    Runcaciguat is a soluble guanylate cyclase stimulator. Runcaciguat combines with selective partial adenosine A1 receptor agonists and can be used in studies about cardiovascular and renal diseases.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    mGluR1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1402936-61-1
  • Formula Weight
    488.3
  • Molecular Formula
    C23H22Cl2F3NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@@]([C@@H](C)C(F)(F)F)(C(=O)Nc1cc(ccc1Cl)[C@@H](CC(O)=O)C1CC1)c1ccc(Cl)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yu SP, Sensi SL, et al. Membrane-delimited modulation of NMDA currents by metabotropic glutamate receptor subtypes 1/5 in cultured mouse cortical neurons. J Physiol. 1997 Mar 15;499 ( Pt 3)(Pt 3):721-32.
molnova catalog
related products
  • Mc-Val-Cit-PAB-Cl

    Mc-Val-Cit-PAB-Cl can be used to conjugate MMAE and antibody to form antibody-MC-vc-MMAE.

  • C-Reactive Protein (...

    CRP, an acute phase serum protein synthesized in response to inflammatory cytokines, produces antitumor effects in animals. The fragment CRP (174-185) (RS-83277) shows similar activity by significantly enhancing the tumoricidal activity of human monocytes and alveolar macrophages in vitro.

  • Transdermal Peptide ...

    Transdermal Peptide TFA (TD 1 Peptide TFA) is an 11-amino acid polypeptide that binds to Na+/K+ -atpase beta-subunit (ATP1B1) and interacts with the C terminal of ATP1B1.Transdermal Peptide TFA can enhance the transmission of some large molecules in the skin.